# With single gene insertion, blind mice regain sight

**URL:** <https://archive.menshealtharchive.com/t/with-single-gene-insertion-blind-mice-regain-sight/2026>\
**Category:** Research Database\
**Created:** [March 15, 2019, 4:41pm UTC](https://archive.menshealtharchive.com/t/with-single-gene-insertion-blind-mice-regain-sight/2026 "2019-03-15T16:41:24Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Science\_Daily](https://yyz1.discourse-cdn.com/flex035/user_avatar/archive.menshealtharchive.com/science_daily/32/325_2.png) [@Science\_Daily](https://archive.menshealtharchive.com/u/Science_Daily)\
**Post date:** [March 15, 2019, 4:41pm UTC](https://archive.menshealtharchive.com/t/with-single-gene-insertion-blind-mice-regain-sight/2026/1 "2019-03-15T16:41:25Z")

</div>

> **[With single gene insertion, blind mice regain sight: Opsins make 'blind'...](https://www.sciencedaily.com/releases/2019/03/190315095808.htm)**
>
> People left blind by retinal degeneration have one option: electronic eye implants. Neuroscientists have now developed an alternative: gene therapy that, in tests, restored vision in blind mice. A gene for green opsin delivered via virus gave blind...

  
People left blind by retinal degeneration have one option: electronic eye implants. Neuroscientists have now developed an alternative: gene therapy that, in tests, restored vision in blind mice. A gene for green opsin delivered via virus gave blind mice enough sight to discern patterns on an iPad at a resolution sufficient for humans to read. Given existing AAV eye therapies already approved, this new therapy could be ready for clinical trials in three years.